Advertising
Showing 1 to 4 of 4 entries
  • «
  • 1
  • »
RISKY BUY

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. The company develops and commercializes diagnostic tools to monitor heart disease. Minimal to no revenues so still very speculative. Largely in the development phase. They signed new contracts with GE Healthcare Corp and new patents are being filed. Unlock Premium - Try 5i Free

Healthcare
BUY

Takes a 2D ultrasound image and converts it to a 3D image that can be observed by surgeons. GE has a large number of ultrasound machines in the marketplace. Has asked them to adapt VentriPoint's system to their machines. China is also interested in adding their tech to their hospitals.

Healthcare
BUY
Takes 2D ultrasound images and coverts them to 3D, especially of the heart. MRI quality without the expense. In partnership with GE. Strong potential for a buyout. In the meantime, customers can buy this cost-saving, lifesaving technology today.
Healthcare
BUY
They take 2D images of the heart and convert to 3D. It's an alternative to an MRI, which is hard to access now. They may be wildly successful in China where they are testing their procedure. If China grants approval, then the opportunity here would be breathtaking.
Healthcare
Showing 1 to 4 of 4 entries
  • «
  • 1
  • »

VentriPoint Diagnostics (VPT-X) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 4

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 4

Stockchase rating for VentriPoint Diagnostics is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

VentriPoint Diagnostics (VPT-X) Frequently Asked Questions

What is VentriPoint Diagnostics stock symbol?

VentriPoint Diagnostics is a Canadian stock, trading under the symbol VPT-X on the TSX Venture Exchange (VPT-CV). It is usually referred to as TSXV:VPT or VPT-X

Is VentriPoint Diagnostics a buy or a sell?

In the last year, 4 stock analysts published opinions about VPT-X. 4 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for VentriPoint Diagnostics .

Is VentriPoint Diagnostics a good investment or a top pick?

VentriPoint Diagnostics was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for VentriPoint Diagnostics .

Why is VentriPoint Diagnostics stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is VentriPoint Diagnostics worth watching?

4 stock analysts on Stockchase covered VentriPoint Diagnostics In the last year. It is a trending stock that is worth watching.

What is VentriPoint Diagnostics stock price?

On 2021-09-24, VentriPoint Diagnostics (VPT-X) stock closed at a price of $0.59.